Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

February 15, 2023 | Last Trade: US$16.86 0.40 -2.32

SAN DIEGO / Feb 15, 2023 / Business Wire / Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Thursday, March 2, 2023 at 2:45pm ET (11:45am PT),
Cowen 43^rd Annual Health Care Conference on Monday, March 6, 2023 at 12:50pm ET (9:50am PT),
Raymond James & Associates’ 44^th Annual Institutional Investors Conference on Wednesday, March 8, 2023 at 9:50am ET (6:50am PT),
Oppenheimer 33^rd Annual Healthcare Conference on Monday, March 13, 2023 at 8:40am ET (5:40am PT), and
Barclays Global Healthcare Conference on Tuesday, March 14, 2023 at 11:15am ET (8:15am PT).

The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

Stock Quote

Last Trade:	US$16.86
Daily Change:	-0.40 -2.32
Daily Volume:	943,013
Market Cap:	US$1.110B

March 19, 2025 Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes March 18, 2025 Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States February 26, 2025 Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance February 25, 2025 Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes February 13, 2025 Tandem Diabetes Care Announces Upcoming Conference Presentations LOAD MORE NEWS

Featured Stock

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE